Pomanda estimates the enterprise value of HEARTS & SCIENCE EMEA LIMITED at £4m based on a Turnover of £5m and 0.79x industry multiple (adjusted for size and gross margin).
hearts & science emea limitedEstimated Valuation
£2.5m
Pomanda estimates the enterprise value of HEARTS & SCIENCE EMEA LIMITED at £2.5m based on an EBITDA of £490k and a 5.16x industry multiple (adjusted for size and gross margin).
hearts & science emea limitedEstimated Valuation
£688.9k
Pomanda estimates the enterprise value of HEARTS & SCIENCE EMEA LIMITED at £688.9k based on Net Assets of £390.5k and 1.76x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Hearts & Science Emea LimitedOverview
Hearts & Science Emea Limited is a live company located in london, SE1 0SW with a Companies House number of 14685572. It operates in the advertising agencies sector, SIC Code 73110. Founded in February 2023, it's largest shareholder is
omnicom media group europe limited
with a 100% stake. Hearts & Science Emea Limited is a startup,
mid sized company, Pomanda has estimated its turnover at
£5m with
unknown
growth in recent years.
Pomanda's financial health check has awarded Hearts & Science Emea Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
4 Strong
1 Regular
4 Weak
Size
annual sales of £5m, make it smaller than the average company (£10m)
£5m - Hearts & Science Emea Limited
£10m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Hearts & Science Emea Limited
- - Industry AVG
Production
with a gross margin of 87.8%, this company has a lower cost of product (43.5%)
87.8% - Hearts & Science Emea Limited
43.5% - Industry AVG
Profitability
an operating margin of 9.7% make it more profitable than the average company (5.2%)
9.7% - Hearts & Science Emea Limited
5.2% - Industry AVG
Employees
with 27 employees, this is below the industry average (44)
27 - Hearts & Science Emea Limited
44 - Industry AVG
Pay Structure
on an average salary of £80k, the company has a higher pay structure (£66k)
£80k - Hearts & Science Emea Limited
£66k - Industry AVG
Efficiency
resulting in sales per employee of £186.6k, this is equally as efficient (£186.4k)
£186.6k - Hearts & Science Emea Limited
£186.4k - Industry AVG
Debtor Days
it gets paid by customers after 27 days, this is earlier than average (59 days)
27 days - Hearts & Science Emea Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 128 days, this is slower than average (43 days)
128 days - Hearts & Science Emea Limited
43 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Hearts & Science Emea Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Hearts & Science Emea Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 96.7%, this is a higher level of debt than the average (68.2%)
96.7% - Hearts & Science Emea Limited
68.2% - Industry AVG
HEARTS & SCIENCE EMEA LIMITED financials
EXPORT
Hearts & Science Emea Limited's latest turnover from December 2023 is £5 million and the company has net assets of £390.5 thousand. According to their latest financial statements, Hearts & Science Emea Limited has 27 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Turnover
5,038,982
Other Income Or Grants
Cost Of Sales
613,601
Gross Profit
4,425,381
Admin Expenses
3,935,394
Operating Profit
489,987
Interest Payable
Interest Receivable
31,589
Pre-Tax Profit
521,576
Tax
-131,051
Profit After Tax
390,525
Dividends Paid
Retained Profit
390,525
Employee Costs
2,160,635
Number Of Employees
27
EBITDA*
489,987
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
Stock & work in progress
Trade Debtors
375,443
Group Debtors
5,948,315
Misc Debtors
5,446,386
Cash
misc current assets
total current assets
11,770,144
total assets
11,770,144
Bank overdraft
Bank loan
Trade Creditors
215,402
Group/Directors Accounts
6,699,582
other short term finances
hp & lease commitments
other current liabilities
3,220,020
total current liabilities
10,135,004
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
1,244,614
provisions
total long term liabilities
1,244,614
total liabilities
11,379,618
net assets
390,526
total shareholders funds
390,526
Dec 2023
Operating Activities
Operating Profit
489,987
Depreciation
Amortisation
Tax
-131,051
Stock
Debtors
11,770,144
Creditors
215,402
Accruals and Deferred Income
3,220,020
Deferred Taxes & Provisions
Cash flow from operations
-7,975,786
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts
6,699,582
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
1,244,614
share issue
1
interest
31,589
cash flow from financing
7,975,786
cash and cash equivalents
cash
overdraft
change in cash
hearts & science emea limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for hearts & science emea limited. Get real-time insights into hearts & science emea limited's credit score, group structure and payment trends.
Perform a competitor analysis for hearts & science emea limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in SE1 area or any other competitors across 12 key performance metrics.
hearts & science emea limited Ownership
HEARTS & SCIENCE EMEA LIMITED group structure
Hearts & Science Emea Limited has no subsidiary companies.
The sole shareholder of Hearts & Science Emea Limited is Omnicom Media Group Europe Limited.
omnicom media group europe limited
100%
hearts & science emea limited directors
Hearts & Science Emea Limited currently has 3 directors.
The longest serving directors include
Mr Guy Marks (Feb 2023) and
Mr Peter Poelzlbauer (Feb 2023).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to hearts & science emea limited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HEARTS & SCIENCE EMEA LIMITED. This can take several minutes, an email will notify you when this has completed.
hearts & science emea limitedCompanies House Filings - See Documents
